Nutex Health Inc. (NUTX) Financial Statements
Nutex Health Inc. (NUTX) reported trailing twelve-month revenue of $846.7M (up 6.9% year on year) and net income of $179.9M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $274.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUTXNutex Health Inc.Follow NUTX — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- 8.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8 | 1.6 | 1.5 | 1.1 | 0.5 | 0.0 | 1.4 | 1.4 | 274.0 | 331.5 | 219.3 | 247.6 | 479.9 | 875.3 | 846.7 | |
| Gross profit | 1.0 | 0.8 | 1.0 | 0.6 | 0.5 | -0.0 | 0.9 | 0.5 | 157.6 | 179.3 | 15.4 | 34.8 | 196.3 | 444.3 | 434.0 | |
| Research & development | — | — | — | — | — | — | — | 0.8 | 0.6 | 0.3 | — | — | — | — | — | |
| Operating income | -0.8 | -1.6 | -0.7 | -0.7 | -0.5 | -5.7 | -0.8 | -6.9 | 153.2 | 170.3 | -406.6 | -31.8 | 130.7 | 275.6 | 364.3 | |
| Pre-tax income | -0.8 | -1.5 | -0.1 | -0.6 | -0.5 | -5.6 | -1.0 | -7.1 | 145.7 | 169.5 | -419.6 | -48.5 | 109.8 | 244.8 | 343.5 | |
| Income tax | — | — | — | — | — | — | — | 0.0 | 0.2 | 1.0 | 13.1 | -5.1 | 15.0 | 64.4 | 71.0 | |
| Net income | -0.4 | -1.6 | 0.3 | -0.7 | 0.1 | 0.6 | -1.0 | -7.1 | 106.0 | 132.6 | -424.8 | -45.8 | 52.1 | 70.8 | 179.9 | |
| Diluted EPS ($) | -0.02 | -0.07 | -0.01 | -0.03 | 0.00 | 0.01 | -0.56 | -1.96 | -1.14 | — | -100.36 | -10.39 | 9.69 | 10.48 | 25.66 | |
| Diluted shares (mn) | — | — | 26.0 | 25.9 | 29.2 | — | — | — | — | — | 4.2 | 4.4 | 5.5 | 6.8 | — |
USD millions · SEC XBRL
Nutex Health Inc. — questions
- What is Nutex Health Inc.'s revenue?
- $846.7M over the twelve months to 2026-06-30, up 6.9% year on year, from its 10-Q and 10-K filings.
- What is Nutex Health Inc.'s net income?
- $179.9M over the twelve months to 2026-06-30.
- What is Nutex Health Inc.'s free cash flow?
- $274.2M over the twelve months to 2026-06-30.
- What are Nutex Health Inc.'s diluted earnings per share?
- $25.66 over the twelve months to 2026-06-30.
Every figure on this page comes from Nutex Health Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.